HIGHOutside partySupplier
sole supplier
“10-K Item 1A: 'we procure certain components and raw materials from a sole supplier'”
CAH · Concentration risk · 10-K extracted
Cardinal Health (CAH) concentration risks
Updated
The most significant concentration Cardinal Health discloses is sole supplier, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Cardinal Health’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 4 disclosed concentrations
HIGH1
MEDIUM3
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMOutside partyCustomer
43%
five largest customers
“10-K Item 1: 'our five largest customers, including CVS Health, accounted for 43 percent of our fiscal 2025 revenue'”
MEDIUMOutside partyCustomer
30%
CVS Health
“10-K Item 1: 'Our largest customer, CVS Health, accounted for 30 percent of our fiscal 2025 revenue'”
MEDIUMOutside partyCustomer
27%
Vizient and Premier GPOs
“10-K Item 1: 'Our two largest GPO relationships in terms of revenue are with Vizient, Inc. and Premier, Inc. ... collectively accounted for 27 percent of our revenue in fiscal 2025'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-06-24The company's concentration profile combines a supplier dependency and a layered set of customer exposures. On the supply side, certain components and raw materials are procured from a sole supplier — a high-share dependency with no disclosed fallback, meaning a disruption to that relationship could affect production or service continuity without an obvious near-term substitute. On the customer side, three overlapping disclosures define the revenue dependency structure. The five largest customers, including CVS Health, accounted for 43% of fiscal 2025 revenue — a medium-share concentration. Within that group, the largest single customer, CVS Health, accounted for 30% of fiscal 2025 revenue — also a medium-share exposure. A separate disclosure covers group purchasing organization relationships: the two largest GPO relationships, Vizient, Inc. and Premier, Inc., collectively accounted for 27% of revenue in fiscal 2025, again medium-share. All three customer-side disclosures carry a dependency character, reflecting specific commercial relationships whose terms and volumes can be renegotiated. Together, the disclosed exposures describe a business where revenue is moderately concentrated in a small number of buyer and purchasing-organization relationships, and where certain input procurement is tied to a sole source. The customer exposures are interconnected — CVS is both a direct customer and likely transacts through GPO channels — so the effective customer concentration may be somewhat higher than the individual disclosures suggest in isolation. The sole supplier dependency adds an independent supply-chain risk that investors should monitor alongside contract renewal timelines on the customer side.
For the engine’s reasoning on CAH’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Distribution
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| CAH● | Cardinal Health, Inc. | 1 | 3 | 0 | 4 |
| COR | Cencora, Inc. | 1 | 1 | 1 | 3 |
| HSIC | Henry Schein, Inc. | 0 | 0 | 0 | 0 |
| MCK | McKesson Corporation | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.